Welcome to our dedicated page for Medical Care Technologies news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on Medical Care Technologies stock.
Medical Care Technologies Inc. (OTC Pink: MDCE) is a technology-focused company that, according to its press releases, develops AI-driven consumer, wellness, and medical applications while operating subsidiaries in the sports memorabilia and collectibles market. The MDCE news feed on Stock Titan aggregates company-issued updates and media coverage so readers can follow developments across its AI app portfolio and its subsidiaries Infinite Auctions and Real Game Used (RGU).
Recent news highlights MDCE’s progress on AI-powered mobile applications in food and nutrition, lifestyle, wellness, and skin lesion pre-screening and risk-awareness. Company updates describe milestones such as completion of internal readiness testing for a skin lesion pre-screening app and iOS App Store approval for an AI-based recipe and nutrition application with planned multi-country, multi-language distribution.
News items also cover the activities of MDCE’s subsidiaries. Infinite Auctions issues announcements about events such as "The Legends Art Auction," featuring original artwork and high-value collectibles tied to well-known cultural and sports figures. Real Game Used reports on the use of its patent-pending AI analysis platform to authenticate and photo-match rare game-used sports memorabilia, including notable discoveries involving historically significant items.
Investors and observers can use this news page to review MDCE’s stated short-term, near-term, and long-term strategic goals, including consumer app launches, development of medical-grade beta applications, and the use of AI-identified memorabilia acquisitions to support technology development. By checking this feed, readers can monitor how the company describes its progress across AI consumer apps, health and wellness tools, and memorabilia-focused operations.
Medical Care Technologies (OTC:MDCE) has launched an innovative AI Facial Health Risk Estimator designed to detect diabetic retinopathy in its early stages. The technology analyzes facial images to identify retinal abnormalities such as microaneurysms, hemorrhages, and vascular leakage, offering a non-invasive screening solution.
CEO Marshall Perkins emphasized that this AI-powered system aims to address the challenge of late diagnosis in diabetic retinopathy, which is a leading cause of preventable blindness globally. The technology promises to improve accessibility to early screening and enhance patient outcomes through early detection.
Medical Care Technologies (OTC:MDCE) has enhanced its AI Facial Health Risk Estimator platform to include detection capabilities for glaucoma and cataracts. The expanded platform now analyzes high-resolution facial and ocular images to identify corneal opacity, lens clouding, and early optic nerve changes.
The integration creates a comprehensive preventive care solution by combining eye health monitoring with existing systemic and dermatological metrics. CEO Marshall Perkins emphasized the platform's holistic approach to early detection of vision-threatening conditions.
Medical Care Technologies (OTC:MDCE) has announced the development of an innovative AI Facial Health Risk Estimator for early diabetes detection. The technology analyzes facial biomarkers including skin tone irregularities, microvascular patterns, and elasticity loss to predict Type 2 diabetes risk before clinical diagnosis.
The non-invasive system uses predictive algorithms to assess diabetes susceptibility through facial analysis, potentially enabling earlier interventions and better patient outcomes, according to CEO Marshall Perkins.
Medical Care Technologies (OTC:MDCE) has unveiled its innovative AI Facial Health Risk Estimator, a technology designed to detect early cardiovascular disease risks through advanced facial imaging analysis.
The system employs deep neural networks to analyze biometric markers including micro-wrinkle density, skin elasticity, and tone variations. By comparing biological age against chronological age, the platform can identify cardiovascular predisposition before clinical symptoms appear, offering a non-invasive alternative to traditional testing methods.
Medical Care Technologies (OTC:MDCE) has unveiled an innovative AI platform for detecting squamous cell carcinoma (SCC), the second most common form of skin cancer. The technology employs advanced machine learning classifiers to identify early warning signs that might be missed during self-examinations.
The AI system utilizes edge-detection algorithms and keratin pattern recognition to identify various SCC indicators including rough patches, persistent lesions, and early ulcerations. A key feature is its ability to differentiate SCC from precancerous conditions through longitudinal comparison modeling, tracking lesion evolution across the entire body.
Medical Care Technologies (OTC:MDCE) has launched an innovative AI platform designed for early detection of basal cell carcinoma (BCC), the most common type of skin cancer. The platform enables at-home screening and monitoring through advanced texture and reflectance analysis technology.
The AI system features sophisticated capabilities including pearly nodule identification, vascular pattern recognition, ulceration tracking, and pixel-level texture classification to distinguish between benign growths and potential carcinomas. This technology aims to address the limited access to dermatology services by providing accessible, non-invasive screening solutions.
Medical Care Technologies (OTC:MDCE) has unveiled a groundbreaking AI platform for early melanoma detection. The technology leverages deep learning algorithms trained on millions of dermatoscopic and clinical images to analyze key melanoma risk factors including asymmetry, border irregularities, color variations, diameter, and evolution monitoring.
The AI system creates longitudinal profiles of moles and lesions, flagging anomalies before progression. This advancement is particularly significant as melanoma, while representing only 1% of skin cancers, causes the majority of skin cancer deaths. When detected early, melanoma survival rates exceed 95%.
Medical Care Technologies (OTC Pink:MDCE) announced that its subsidiary Infinite Auctions LLC has secured a $2.54 million sports memorabilia inventory. The collection includes high-value assets such as a LeBron James 2016 NBA Finals game-worn jersey valued at nearly $1 million and a rare Tom Brady 1/1 card worth potentially hundreds of thousands based on recent comparable sales.
The company is leveraging these liquid assets to support its primary mission of developing AI-powered healthcare diagnostics across multiple verticals including mental health tracking, wound monitoring, and melanoma detection. The strategic move aims to provide financial flexibility for R&D and accelerate the commercialization of its AI healthcare platform.
The global sports memorabilia market is projected to grow from $26.1 billion in 2021 to over $40 billion by 2030.Medical Care Technologies (OTC:MDCE) reported that its subsidiaries have generated over $1 million in revenue before Q3 2025's end. Infinite Auctions achieved significant sales, including a LeBron James NBA Finals jersey for $242,000, while Real Game Used generated $58,948 from authentication services.
The company plans to use this revenue to achieve a debt-free balance sheet by year-end and fund its AI healthcare technology development. MDCE's roadmap includes advancing patent applications, refining AI health screening models, completing beta testing, publishing case studies, and preparing for FDA submissions.
Medical Care Technologies (OTC PINK:MDCE) has announced its projection to achieve debt-free status by the end of Q4 2025, driven by strong performance from its subsidiaries. The company's two main revenue generators, Infinite Auctions LLC (sports memorabilia auction house) and Real Game Used LLC (AI-powered authentication platform), have reported robust sales growth.
MDCE has also filed a U.S. provisional patent application for an AI-driven diagnostic platform that aims to transform smartphones into preventive healthcare screening tools, capable of detecting conditions like melanoma, wound infections, and mental health disorders. The company plans to leverage its improving financial position to advance this healthcare technology initiative.